Betting on Healthcare’s Future
OrbiMed’s portfolio stretches across the healthcare spectrum:
-
AbCellera, an antibody discovery partner.
-
BioAge Labs, advancing drugs to combat obesity and aging.
-
Cyrus Biotechnology, which provides protein modeling software for pharma and industrial applications.
-
Forward Therapeutics, developing treatments for chronic inflammatory disorders.
The new $1.86 billion fund cements OrbiMed’s role as one of the most influential investors fueling healthcare’s evolution, with resources to back startups and multinational players alike.
